
Calyxt Inc
Prices are adjusted according to historical splits.

Vitals
- Today's Low:
- $0.303
- Today's High:
- $0.35
- Open Price:
- $0.32
- 52W Low:
- $0.125
- 52W High:
- $1.33
- Prev. Close:
- $0.33
- Volume:
- 227700
Company Statistics
- Market Cap.:
- $16.79 million
- Book Value:
- 0.148
- Revenue TTM:
- $157000
- Operating Margin TTM:
- -14248.41%
- Gross Profit TTM:
- $157000
- Profit Margin:
- 0%
- Return on Assets TTM:
- -46.91%
- Return on Equity TTM:
- -158.12%
Company Profile
Calyxt Inc had its IPO on 2017-07-20 under the ticker symbol CLXT.
The company operates in the Consumer Defensive sector and Packaged Foods industry. Calyxt Inc has a staff strength of 48 employees.
Stock update
Shares of Calyxt Inc opened at $0.32 at the start of the last trading session i.e. 2023-03-19.
The stocks traded within a range of $0.3 - $0.35, and closed at $0.34.
This is a +3.03% increase from the previous day's closing price.
A total volume of 227,700 shares were traded at the close of the day’s session.
In the last one week, shares of Calyxt Inc have slipped by -7.86%.
Calyxt Inc's Key Ratios
Calyxt Inc has a market cap of $16.79 million, indicating a price to book ratio of 0.8466 and a price to sales ratio of 4.0321.
In the last 12-months Calyxt Inc’s revenue was $157000 with a gross profit of $157000 and an EBITDA of $-20836000. The EBITDA ratio measures Calyxt Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Calyxt Inc’s operating margin was -14248.41% while its return on assets stood at -46.91% with a return of equity of -158.12%.
In Q4, Calyxt Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 97.8%.
Calyxt Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
- 0
Its diluted EPS in the last 12-months stands at $-0.41 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Calyxt Inc’s profitability.
Calyxt Inc stock is trading at a EV to sales ratio of 6.8641 and a EV to EBITDA ratio of -0.745. Its price to sales ratio in the trailing 12-months stood at 4.0321.
Calyxt Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $22.42 million
- Total Liabilities
- $1.66 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $11000
- Dividend Payout Ratio
- 0%
Calyxt Inc ended 2023 with $22.42 million in total assets and $0 in total liabilities. Its intangible assets were valued at $22.42 million while shareholder equity stood at $7.23 million.
Calyxt Inc ended 2023 with $0 in deferred long-term liabilities, $1.66 million in other current liabilities, 291000.00 in common stock, $-212151000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $3.43 million and cash and short-term investments were $3.43 million. The company’s total short-term debt was $97,000 while long-term debt stood at $0.
Calyxt Inc’s total current assets stands at $4.13 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $340000.00 and inventory worth $0.
In 2023, Calyxt Inc's operating cash flow was $0 while its capital expenditure stood at $11000.
Comparatively, Calyxt Inc paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- $0.34
- 52-Week High
- $1.33
- 52-Week Low
- $0.125
- Analyst Target Price
- $1
Calyxt Inc stock is currently trading at $0.34 per share. It touched a 52-week high of $1.33 and a 52-week low of $1.33. Analysts tracking the stock have a 12-month average target price of $1.
Its 50-day moving average was $0.33 and 200-day moving average was $0.24 The short ratio stood at 0.63 indicating a short percent outstanding of 0%.
Around 5427.5% of the company’s stock are held by insiders while 500.3% are held by institutions.
Frequently Asked Questions About Calyxt Inc
Similar Industry Stocks (Packaged Foods)
Most Active
Top Gainers
Top Losers
About
Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the exclusive license of an improved quality alfalfa seed in the United States and internationally. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota.